Prakiraan rega marang bathi: Qilian International Holding Group (QLI)
Demand for Chinese pharmaceutical raw materials remains stable, minimizing business cyclicality for Qilian International (QLI). The issuer's forward P/E demonstrates a correlation between share prices and expected earnings, with 0.00 representing the current metric. Regulatory reforms and pressure from the public sector are compressing sales margins; however, owning plants in agricultural zones guarantees a steady distribution of chemical components to farmers.
Rincian metrik keuangan lan pasar qlsyy.net (QLI)
- nilai saham lan prakiraan konsensus rega:
- indikator kapitalisasi bursa perusahaan:
- statistik nilai buku emiten:
- informasi babagan utang lan solvabilitas:
Utang marang Ekuitas Qilian International|QLI - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas qlsyy.net|QLI - Tanggungan utang total perusahaan|Utang-utang marang kapitalisasi buku Qilian International Holding|QLI - Gunggunge utang jangka dawa|Utang jangka cendhak perusahaan Qilian International|Rasio cepet qlsyy.net
- statistik bathi lan rasio pasar:
QLI - Asil keuangan resik|Proyeksi bathi mangsa ngarep Qilian International|QLI - Pangali P/E|Rega marang bathi mangsa ngarep Qilian International Holding|QLI - Rasio P/E diaturake wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Qilian International|QLI - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) Qilian International|QLI - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan qlsyy.net|QLI - Wutah bathi saben saham ing taun iki|Prakiraan wutah bathi saben saham kanggo taun ngarep Qilian International
- informasi babagan volume dodolan lan pendapatan:
Analisis wiwitan perusahaan:Qilian International Corp
For Qilian International (QLI), which relies on stable demand within the traditional medicine sector, the company's expected P/E multiple reflects the market valuation of future cash flows. This indicator is calculated as the ratio of the current share price to the projected earnings per share, allowing investors to assess the premium paid for the asset given the issuer's sustainable operating margin and robust FCF.
Pesaing utama
Rega marang bathi mangsa ngarep haleon.com (HLN)|KVUE (Kenvue Health) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Verona Pharma PLC VRNA|Jyong Biotech (MENS) - Rasio prakiraan rega marang bathi|LGND: Prakiraan rega marang bathi|Amneal - Rasio kapitalisasi marang bathi mangsa ngarep|PRGO: Pangali Forward P/E|Alvotech Corp - Pangali mangsa ngarep rega marang bathi|LQDA (Liquidia Corp) - Pangali Forward P/E|Rasio prakiraan rega marang bathi glpg.com GLPG|Rega marang bathi mangsa ngarep ANI Pharmaceuticals, Inc. (ANIP)|MNKD (MannKind Corp) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E AMPH (Amphastar Pharmaceuticals Inc)|PCRX (Pacira) - Rasio rega marang bathi sing dikarepake|SPRY - Rega marang bathi mangsa ngarep|Pangali mangsa ngarep rega marang bathi TBPH (Theravance Biopharma)|AQST (aquestive.com) - Prakiraan rega marang bathi|Rasio rega marang bathi sing dikarepake SCPH (scPharmaceuticals, Inc.)|Prakiraan rega marang bathi TECX|Tonix Pharmaceuticals (TNXP) - Kapitalisasi marang proyeksi bathi|Pangali Forward P/E SXTC|Pangali Forward P/E Eupraxia Pharma (EPRX)|Rega marang bathi mangsa ngarep BioHarvest Sciences Inc. BHST|EXOZ - Prakiraan rega marang bathi|ORMP: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi ENTX (enterabio.com)|MindWalk Therapeutics (HYFT) - Rega marang bathi mangsa ngarep|Rasio prakiraan rega marang bathi abvcpharma.com (ABVC)|Rega marang bathi mangsa ngarep Cumberland Pharma|Rega marang bathi mangsa ngarep QNTM|Pangali Forward P/E FGEN|TELO (Telomir Pharma) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Rani Therapeutics Holdings RANI|SNYR - Prakiraan rega marang bathi|RLYB - Rega marang bathi mangsa ngarep|Kapitalisasi marang proyeksi bathi lexariabioscience.com LEXX|PULM: Pangali Forward P/E|Rasio rega marang bathi mangsa ngarep PTHL|Rega marang bathi mangsa ngarep Aptorum Group Limited|LYRA (Lyra Therapeutics, Inc.) - Rasio kapitalisasi marang bathi mangsa ngarep|Pangali Forward P/E IBO|Kapitalisasi marang proyeksi bathi TNF Pharmaceuticals, Inc.|Pangali Forward P/E YCBD (cbdMD, Inc.)|PRFX (PainReform Corp) - Rasio rega marang bathi sing dikarepake|CYTO: Prakiraan rega marang bathi|LIPO - Pangali Forward P/E|OptiNose, Inc. (OPTN) - Rega marang bathi mangsa ngarep|PIRS - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep Procaps|Prakiraan rega marang bathi Petros (PTPI)|Pangali Forward P/E SLRN|Rasio kapitalisasi marang bathi mangsa ngarep TFFP
